Webinar: Optimising viral vector manufacturing with CDMO expertise and innovation

News: OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category

Results and presentation

Financial reports

Year Full-year results Half-year results Annual report & accounts
2025
2024
2023
2022
2021
2020

Latest corporate presentation

PDF
Preliminary Results for the year ended 31 December 2025

Results and corporate presentations

Link PDF
Preliminary results for the year ended 31 December 2025
Jefferies London Healthcare conference presentation 2025
Interim results for the six months ended 30 June 2025 - 23 September 2025
OXB interim results presentation 2025 - 23 September 2025
Oxford Biomedica PLC interim results for the six months ended 30 June 2025 - 23 September 2025
Preliminary results for the year ended 31 December 2024 - 9th April 2025

Webcasts and audio

Audio Link PDF
Preliminary Results for the year ended 31 December 2025
Jefferies Global Healthcare Conference 2025 - 15 December 2025
Webinar: Optimising Viral Vector Manufacturing with CDMO Expertise and Innovation - 18 November 2025
Stifel US Healthcare Conference 2025 - 17 November 2025
Webinar: Driving Down the Cost- Optimising CGT with the Right CDMO Partner - 13 November 2025
Interim results for 6 months ended 30 June 2025 - 2 October 2025
OXB-Investors-results and presentation-image grid 1-832x480px
OXB-Investors-results and presentation-image grid 2-832x480px
OXB-Investors-results and presentation-image grid 3-832x480px